Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer.

Rose DP, Gracheck PJ, Vona-Davis L.

Cancers (Basel). 2015 Oct 26;7(4):2147-68. doi: 10.3390/cancers7040883. Review.

2.

System-level design of an RFID sweat electrolyte sensor patch.

Rose DP, Ratterman M, Griffin DK, Hou L, Kelley-Loughnane N, Naik RK, Hagen JA, Papautsky I, Heikenfeld J.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4038-41. doi: 10.1109/EMBC.2014.6944510.

PMID:
25570878
3.

Adhesive RFID Sensor Patch for Monitoring of Sweat Electrolytes.

Rose DP, Ratterman ME, Griffin DK, Hou L, Kelley-Loughnane N, Naik RR, Hagen JA, Papautsky I, Heikenfeld JC.

IEEE Trans Biomed Eng. 2015 Jun;62(6):1457-65. doi: 10.1109/TBME.2014.2369991. Epub 2014 Nov 11.

PMID:
25398174
4.

Tobacco cessation outcomes in a cohort of patients attending a chest medicine outpatient clinic in Bangalore city, southern India.

Mony PK, Rose DP, Sreedaran P, D'Souza G, Srinivasan K.

Indian J Med Res. 2014 Apr;139(4):523-30.

5.

Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.

Vona-Davis L, Rose DP, Gadiyaram V, Ducatman B, Hobbs G, Hazard H, Kurian S, Abraham J.

J Cancer Epidemiol. 2014;2014:170634. doi: 10.1155/2014/170634. Epub 2014 Jan 9.

6.

The obesity-inflammation-eicosanoid axis in breast cancer.

Vona-Davis L, Rose DP.

J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):291-307. doi: 10.1007/s10911-013-9299-z. Epub 2013 Oct 30. Review.

PMID:
24170420
7.

Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer.

Rose DP, Vona-Davis L.

Biofactors. 2014 Jan-Feb;40(1):1-12. doi: 10.1002/biof.1109. Epub 2013 Jul 16. Review.

PMID:
23857944
8.

The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression.

Rose DP, Vona-Davis L.

Endocr Relat Cancer. 2012 Nov 9;19(6):R225-41. doi: 10.1530/ERC-12-0203. Print 2012 Dec. Review.

PMID:
22936542
9.
10.

Interaction between menopausal status and obesity in affecting breast cancer risk.

Rose DP, Vona-Davis L.

Maturitas. 2010 May;66(1):33-8. doi: 10.1016/j.maturitas.2010.01.019. Epub 2010 Feb 23. Review.

PMID:
20181446
11.

Influence of obesity on breast cancer receptor status and prognosis.

Rose DP, Vona-Davis L.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1091-101. doi: 10.1586/era.09.71. Review.

PMID:
19671029
12.

Angiogenesis, adipokines and breast cancer.

Vona-Davis L, Rose DP.

Cytokine Growth Factor Rev. 2009 Jun;20(3):193-201. doi: 10.1016/j.cytogfr.2009.05.007. Epub 2009 Jun 10. Review.

PMID:
19520599
13.

The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.

Vona-Davis L, Rose DP.

J Womens Health (Larchmt). 2009 Jun;18(6):883-93. doi: 10.1089/jwh.2008.1127. Review.

PMID:
19514831
14.

Triple-negative breast cancer and obesity in a rural Appalachian population.

Vona-Davis L, Rose DP, Hazard H, Howard-McNatt M, Adkins F, Partin J, Hobbs G.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3319-24. doi: 10.1158/1055-9965.EPI-08-0544.

15.

Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.

Rose DP, Haffner SM, Baillargeon J.

Endocr Rev. 2007 Dec;28(7):763-77. Epub 2007 Nov 2. Review.

PMID:
17981890
16.

Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.

Vona-Davis L, Howard-McNatt M, Rose DP.

Obes Rev. 2007 Sep;8(5):395-408. Review.

PMID:
17716297
17.

Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.

Vona-Davis L, Rose DP.

Endocr Relat Cancer. 2007 Jun;14(2):189-206. Review.

PMID:
17639037
18.

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5.

19.

Obesity, adipokines, and prostate cancer (review).

Baillargeon J, Rose DP.

Int J Oncol. 2006 Mar;28(3):737-45. Review.

PMID:
16465380
20.

Obesity, adipocytokines, and insulin resistance in breast cancer.

Rose DP, Komninou D, Stephenson GD.

Obes Rev. 2004 Aug;5(3):153-65. Review.

PMID:
15245384
21.

Breast cancer and obesity: an update.

Stephenson GD, Rose DP.

Nutr Cancer. 2003;45(1):1-16. Review.

PMID:
12791499
22.

Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).

Rose DP, Gilhooly EM, Nixon DW.

Int J Oncol. 2002 Dec;21(6):1285-92. Review.

PMID:
12429979
23.

Mammography screening and breast cancer biology in African American women--a review.

Royak-Schaler R, Rose DP.

Cancer Detect Prev. 2002;26(3):180-91. Review.

PMID:
12269764
24.
25.

Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP.

Melanoma Res. 2001 Aug;11(4):355-69.

PMID:
11479424
26.

Tumor biology and prognosis in black breast cancer patients: a review.

Rose DP, Royak-Schaler R.

Cancer Detect Prev. 2001;25(1):16-31. Review.

PMID:
11270418
27.

Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids.

Rose DP, Connolly JM.

Nutr Cancer. 2000;37(2):119-27. Review.

PMID:
11142082
28.

Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.

Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z.

Cancer Res. 2000 Aug 1;60(15):4139-45.

30.

Omega-3 fatty acids as cancer chemopreventive agents.

Rose DP, Connolly JM.

Pharmacol Ther. 1999 Sep;83(3):217-44. Review.

PMID:
10576293
31.
32.
33.
34.
36.

Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype.

Morse-Gaudio M, Connolly JM, Rose DP.

Int J Oncol. 1998 Jun;12(6):1349-54.

PMID:
9592198
37.

Dietary fat and breast cancer metastasis by human tumor xenografts.

Rose DP, Connolly JM.

Breast Cancer Res Treat. 1997 Nov-Dec;46(2-3):225-37. Review.

PMID:
9478277
38.

Dietary fatty acids and prevention of hormone-responsive cancer.

Rose DP.

Proc Soc Exp Biol Med. 1997 Nov;216(2):224-33. Review.

PMID:
9349691
39.

Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies.

Rose DP.

Am J Clin Nutr. 1997 Dec;66(6 Suppl):1513S-1522S. doi: 10.1093/ajcn/66.6.1513S. Review.

PMID:
9394709
40.

Dietary fatty acids and cancer.

Rose DP.

Am J Clin Nutr. 1997 Oct;66(4 Suppl):998S-1003S. doi: 10.1093/ajcn/66.4.998S. Review.

PMID:
9322580
41.
42.

Dietary Fat, Fatty Acids and Breast Cancer.

Rose DP.

Breast Cancer. 1997 Mar 25;4(1):7-16.

PMID:
11091570
43.

Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice.

Connolly JM, Coleman M, Rose DP.

Nutr Cancer. 1997;29(2):114-9.

PMID:
9427973
45.

Fatty acid regulation of breast cancer cell growth and invasion.

Rose DP, Connolly JM, Liu XH.

Adv Exp Med Biol. 1997;422:47-55. Review. No abstract available.

PMID:
9361814
46.

Diet and breast cancer: opportunities for prevention and intervention.

Rose DP, Connolly JM, Liu XH.

Prog Clin Biol Res. 1997;396:147-58. Review. No abstract available.

PMID:
9108596
48.
50.

Breast cancer chemoprevention: clinical trials and research.

Noguchi M, Rose DP, Miyazaki I.

Oncology. 1996 May-Jun;53(3):175-81. Review.

PMID:
8643218

Supplemental Content

Support Center